Cited by 724Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk FactorsCardiac Imaging and Diagnostics

Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study

Open access
d'Arcy, Joanna L., Coffey, Sean, Loudon, Margaret A., Kennedy, Andrew, Pearson-Stuttard, Jonathan, Birks, Jacqueline, Frangou, Eleni, Farmer, Andrew J. +4 more·2016·European Heart Journal

Abstract

BACKGROUND: Valvular heart disease (VHD) is expected to become more common as the population ages. However, current estimates of its natural history and prevalence are based on historical studies with potential sources of bias. We conducted a cross-sectional analysis of the clinical and epidemiological characteristics of VHD identified at recruitment of a large cohort of older people. METHODS AND RESULTS: We enrolled 2500 individuals aged ≥65 years from a primary care population and screened for undiagnosed VHD using transthoracic echocardiography. Newly identified (predominantly mild) VHD was detected in 51% of participants. The most common abnormalities were aortic sclerosis (34%), mitral regurgitation (22%), and aortic regurgitation (15%). Aortic stenosis was present in 1.3%. The likelihood of undiagnosed VHD was two-fold higher in the two most deprived socioeconomic quintiles than in the most affluent quintile, and three-fold higher in individuals with atrial fibrillation. Clinically significant (moderate or severe) undiagnosed VHD was identified in 6.4%. In addition, 4.9% of the cohort had pre-existing VHD (a total prevalence of 11.3%). Projecting these findings using population data, we estimate that the prevalence of clinically significant VHD will double before 2050. CONCLUSIONS: Previously undetected VHD affects 1 in 2 of the elderly population and is more common in lower socioeconomic classes. These unique data demonstrate the contemporary clinical and epidemiological characteristics of VHD in a large population-based cohort of older people and confirm the scale of the emerging epidemic of VHD, with widespread implications for clinicians and healthcare resources.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehw229

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A study of 2,500 people aged 65 years or older found 4.9% previously diagnosed with clinically significant VHD and another 6.4% with undiagnosed VHD, more than doubling overall prevalence.

    “A study of 2,500 people 65 years of age or older found that 4.9% were previously diagnosed with clinically significant (graded moderate or severe) VHD and found another 6.4% with undiagnosed VHD more than doubling the overall prevalence14.”

    From Detecting structural heart disease from electrocardiograms using AI (2025) · cites this paper as [14]

    The Abstract reports 2,500 participants aged ≥65, 6.4% with undiagnosed moderate or severe VHD, and 4.9% with pre-existing VHD, yielding 11.3% overall—more than twice 4.9%. However, the Discussion says the previously diagnosed group was excluded from screening and its clinical significance was assumed, not confirmed by moderate-or-severe grading. Page numbers are not available in the supplied copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. d'Arcy JL, Prendergast BD, Chambers JB, Ray SG, Bridgewater B. Valvular heart dis- ease: the next cardiac epidemic. Heart 2011;97:91 -93.
  2. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baro ´n-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Scha ¨fers H-J, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardi- ology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451 -2496.
  3. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Ba ¨rwolf C, Levang OW, Tornos P, Vanoverschelde J-L, Vermeer F, Boersma E, Ravaud P, Vahanian A. A pro- spective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231 -1243.
  4. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368: 1005 -1011.
  5. Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epi- demiology of valvular aortic stenosis. the Tromsø study. Heart 2013;99:396 -400.
  6. Coffey S, D'Arcy JL, Loudon MA, Mant D, Farmer AJ, Prendergast BD. The Ox- VALVE population cohort study (OxVALVE-PCS) -population screening for un- diagnosed valvular heart disease in the elderly: study design and objectives. Open Hear 2014;1:e000043.
  7. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Recommendations for evaluation of the severity of na- tive valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777 -802.
  8. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quin ˜ones M. Echocardiographic assessment of valve sten- osis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10: 1 -25.
  9. Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, Hare R, Wosornu D, Lancashire RJ. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001;358:439-444.
  10. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO. Recruit- ment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993;3:358-366.
  11. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Wood EA, Howard BV, Welty TK, Lee ET, Fabsitz RR. Relations of Doppler stroke volume and its compo- nents to left ventricular stroke volume in normotensive and hypertensive Ameri- can Indians: the Strong Heart Study. Am J Hypertens 1997;10:619 -628.
  12. Lindroos M, Kupari M, Heikkila ¨J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220 -1225.
  13. Lebowitz NE, Bella JN, Roman MJ, Liu JE, Fishman DP, Paranicas M, Lee ET, Fabsitz RR, Welty TK, Howard BV, Devereux RB. Prevalence and correlates of aor- tic regurgitation in American Indians: the Strong Heart Study. J Am Coll Cardiol 2000; 36:461-467.
  14. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897 -902.
  15. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, Applebaum RM, Kronzon I. The risk of the development of aortic stenosis in pa- tients with 'benign' aortic valve thickening. Arch Intern Med 2002;162:2345 -2347.
  16. Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, Otto CM, Griffin BP. Clinical factors, but not C-reactive protein, predict progression of cal- cific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007; 50:1992 -1998.
  17. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic- valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142 -147.
  18. Dunning J, Gao H, Chambers J, Moat N, Murphy G, Pagano D, Ray S, Roxburgh J, Bridgewater B. Aortic valve surgery: marked increases in volume and significant de- creases in mechanical valve use-an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. J Thorac Cardiovasc Surg 2011;142:776 -782.
  19. Basso C, Boschello M, Perrone C, Mecenero A, Cera A, Bicego D, Thiene G, De Dominicis E. An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol 2004;93:661 -663.
  20. Nistri S, Basso C, Marzari C, Mormino P, Thiene G. Frequency of bicuspid aortic valve in young male conscripts by echocardiogram. Am J Cardiol 2005;96:718 -721.
  21. Movahed M-R, Hepner AD, Ahmadi-Kashani M. Echocardiographic prevalence of bicuspid aortic valve in the population. Heart Lung Circ 2006;15:297 -299.
  22. Tutar E, Ekici F, Atalay S, Nacar N. The prevalence of bicuspid aortic valve in new- borns by echocardiographic screening. Am Heart J 2005;150:513 -515.
  23. Pearson-Stuttard J, Bajekal M, Scholes S, O'Flaherty M, Hawkins NM, Raine R, Capewell S. Recent UK trends in the unequal burden of coronary heart disease. Heart 2012;98:1573 -1582.
  24. January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS Guideline for the Manage- ment of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Prac- tice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64: 2246-2280.
  25. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey J-Y, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibril- lation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-2429.
  26. De Caterina R, Camm AJ. What is 'valvular' atrial fibrillation? A reappraisal. Eur Heart J 2014;35:3328 -3335.
  27. Jones A, Cronin PA, Bowen M. Comparison of risk factors for coronary heart dis- ease among attenders and non-attenders at a screening programme. Br J Gen Pract 1993;43:375 -377.
  28. Aronow WS, Ahn C, Kronzon I. Prevalence of echocardiographic findings in 554 men and in 1,243 women aged .60 years in a long-term health care facility. Am J Cardiol 1997;79:379 -380.
  29. Aronow WS, Kronzon I. Prevalence and severity of valvular aortic stenosis deter- mined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol 1991;67:776 -777.
  30. Patel DK, Green KD, Fudim M, Harrell FE, Wang TJ, Robbins MA. Racial differences in the prevalence of severe aortic stenosis. J Am Heart Assoc 2014;3: e000879.
  31. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790 -1798.
  32. Thyregod HGH, Steinbru ¨chel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrøm T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Søndergaard L. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Car- diol 2015;65:2184 -2194.

Cited by

Sorted by citations

Authors
d'Arcy, J. L., Coffey, S., Loudon, M. A., Kennedy, A., Pearson-Stuttard, J., Birks, J., Frangou, E., Farmer, A. J., Mant, D., Wilson, J., Myerson, S. G., & Prendergast, B. D.
Affiliations
  • NIHR Oxford Biomedical Research Centre (GB)
  • University of Oxford (GB)
Corresponding author
Prendergast, Bernard D.
Venue
European Heart Journal
Published
2016-06-26
Volume
37
Issue
47
Pages
3515-3522
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2470498562
Cited by
724
References
3
Citations by year
2026: 82 · 2025: 130 · 2024: 106 · 2023: 83 · 2022: 82 · 2021: 72 · 2020: 49 · 2019: 54 · 2018: 31 · 2017: 28 · 2016: 6 · 2015: 1
FWCI
32.67
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institute of Health Research (NIHR) Thames Valley Comprehensive Local Research Network (UKCRN ID 6086)
  • NIHR Oxford Biomedical Research Centre
  • NIHR School for Primary Care Research
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
valvular heart disease, older adults, aortic valve sclerosis, mitral regurgitation, aortic regurgitation, aortic stenosis, socioeconomic deprivation, atrial fibrillation, prevalence, transthoracic echocardiography, primary care screening
MeSH terms
Aged, Cross-Sectional Studies, Echocardiography, Heart Valve Diseases, Humans, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review